Flow-Mediated Vasodilation Is Not Attenuated in Hypertensive Pregnancies Despite Biochemical Signs of Inflammation
Table 2
(a) FMD during pregnancy and postpartum, data are expressed as means, (minimums, maximums) and standard deviations. Normal pregnancies compared to hypertensive pregnancies
FMD (%)
Pregnancy
Postpartum
Control group ()
8.8 (−1.5–21) ± 5.1
7.9 (2.9–16) ± 3.5
Hypertensive pregnancies ()
11 (−2.9–24) ± 6.3
8.0 (1.6–16) ± 4.2
P
(b) FMD in normal, hypertensive end preeclamptic women during pregnancy and postpartum. The mean, minimums, maximums, and standard deviations
Mean baseline diameter of the a. brachialis in pregnancy (mm)
Mean FMD during pregnancy %
Mean FMD in nitrotest during pregnancy
Mean baseline diameter of the a. brachialis postpartum (mm)
Mean FMD postpartum %
Mean FMD in nitro test postpartum
Normal pregnancy ()
0.33 (0.27–0.43) ± 0.04
8.8%
22%
0.30 (0.25–0.38) ± 0.03
7.9%
26%
Hypertensive pregnancy ()
0.35 (0.30–0.45) ± 0.04
10%
19%
0.32 (0.29–0.36) ± 0.03
8.5%
26%
Preeclamptic pregnancies ()
0.31 (0.24–0.34) ± 0.03
11%
21%
0.30 (0.25–0.34) ± 0.04
7.2%
28%
Difference btw the groups
HT versus PE
NS/HT versus PE
NS
NS
NS/NS
NS
pregnancy versus postpartum
Control , HT , PE NS
PE
Control HT PE
(c) FMD during pregnancy and postpartum. Means, minimums, and maximums and SDs
